Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

Scientists at Johns Hopkins University in the US have developed a new blood test that can detect signs of cancer up to three ...

Shield is the first FDA-approved blood test for primary colorectal ... that would use blood samples to detect colorectal cancers. The device detects a colon cancer secreted protein known as ...

THIS TEST DOCTORS HERE AT E.G.H. TELL ME IS A GAME CHANGER. IT CAN MINIMIZE LATE STAGE CANCER DIAGNOSIS AND ACTUALLY DETECT CANCER YEARS BEFORE A PATIENT WOULD HAVE EVER KNOWN WITH ONE BLOOD TEST ... ...

While the previous PATHFINDER study—a prospective, year-long examination of about 6,600 people—showed that Galleri could more ...

Cancer research reveals blood tests can detect tumor-derived mutations years before diagnosis. Johns Hopkins scientists ...

American researchers from Johns Hopkins University discovered that genetic material shed from tumors can be identified in the ...

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an ...

Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

Such evidence can show up in a person’s blood three-and-a-half years before their cancer would be otherwise diagnosed ...